Late breaking call for poster abstracts

Abstracts are due by 11:59 PST, April 5, 2024

2024 CAPO Late breaking call for poster abstracts

Submissions CLOSED

The Canadian Association of Psychosocial Oncology (CAPO) is accepting abstracts for posters for the 39th Annual Conference to be held in Calgary, Alberta from June 6 to 7, 2024. The conference will not be offered virtually this year.

The CAPO 2024 Scientific Committee will select abstracts for additional posters by April 26, 2024. The submitting author will receive an email with the decision. If a primary author cannot attend the conference, that author should assign a replacement. The scientific committee reserves the right to reallocate abstracts as necessary. All presenting authors must register for the conference.
 
For abstract-related inquiries, please contact [email protected]


This conference brings together key stakeholders including people with lived experience as well as multidisciplinary professionals from nursing, psychology, psychiatry, social work, spiritual care, nutrition, medicine, rehabilitation medicine, occupational health and radiation therapy for both adult and pediatric populations. Together, we seek to explore, share, learn and discuss psychosocial and physical aspects of cancer. Participants include clinicians, researchers, educators in cancer care, patient advocacy organizations, community-based organizations and patient representatives. Patients, caregivers and family members are strongly encouraged to submit abstracts that speak to their role in managing cancer experiences and care.

We invite abstracts on a wide range of topics in cancer care and stages of disease ranging from prevention and early diagnosis, to treatment and survivorship, to palliative and end-of-life care. Submissions can be reports of observational studies and clinical trials, innovative programs and service delivery models, systematic reviews, study protocols, clinical guidelines and best practice and local, regional, national and international approaches to build capacity in research, education and clinical care. Patients as co-presenters are encouraged where funding is available to ensure their participation. Patient oriented content is also encouraged.

Abstract Regulations & Guidelines

With abstract submission, the first author (submitting author):

  • Accepts responsibility for the accuracy of the submitted abstract.
  • Confirms that all authors are aware of and agree to the content of the abstract and support the data presented.
  • Confirms the abstract is not under review for presentation or publication elsewhere and has not been previously presented or published in its current format.
  • Gives permission for the abstract, when selected for presentation, to be published in the Conference Proceedings.   
  • Confirms that the primary presenter/senior author will register and attend the conference. Where patient partners have been engaged, funding for their participation is the responsibility of the primary presenter/senior author.

Presentation Types:

Poster Presentations – consist of 4’ x 4’ (1.2 M x 1.2M) display presentations for completed or in progress work. Submissions for poster presentations should follow the clinical or research format (see below). At least one author of an accepted poster abstract must be present during the assigned session. Poster sessions may run concurrently with other conference sessions.

Submission formats

To be considered, abstracts must follow these guidelines:

  • Abstract titles should be brief (maximum of 30 words) and should reflect the content of the submission.
  • Commercial entities/names may not be used in the abstract title.
  • No more than 10 authors can be listed per submission.
  • Each author’s professional title, institutional affiliation(s), city and country must be provided.
  • An abstract is required for all symposium, oral and poster submissions.
  • Abstract content should be submitted in structured paragraph format.
  • Submissions must follow the clinical or research format and either can present patient-oriented content.
  • Submissions may state measurement in clinical care and research in PSO

Clinical Abstracts:

Clinical content can include development of innovative programs, interventions or service delivery models of care.

Word Limit: 250 words.

Headings (do not include these in the body of your submission):

  • Background/rationale
  • Methods (needs assessment, theoretical models, interventions, outcomes)
  • Impact on practice
  • Discussion (lessons learned, future directions).

Research Abstracts:

Research content must refer to work that relies on scientific methods or theory development. This can include protocols, literature reviews and studies.

Word Limit: 250 words.

Headings (do not include these in the body of your submission):

  • Objectives/purpose
  • Methodology
  • Results
  • Conclusion and clinical implications.

For submissions, ensure that you provide the following:

  • Abstract Title
  • Name, City and Affiliation of all authors
  • Presenting author
  • Submission Type
  • Theme
  • Abstract content

DO NOT ENTER IN ALL CAPS. Submissions that provide approval to publish will be published as they are submitted. Failure to follow the prescribed directions may impact inclusion in the publication. 

Abstract submission is in text format only and the pre-defined topic and type must be indicated. Upon submission, a confirmation will be sent to the email of the account holder. Please note: This email is a confirmation of abstract submission and NOT a notice of acceptance.

Abstract Themes (Research and Clinical)

  • Abstracts will be accepted for the following themes:


  • A.    Adapting PSO care in LMI countries

  • B.    Cancer treatment-related symptom and toxicity management

  • C.     Cancer care across the life span (children, adolescent & young adults, adults, and older adults)

  • D.    Community-based and volunteer cancer care services

  • E.     Complementary and integrative cancer care

  • F.     Digital health and cancer care

  • G.    Exercise/pre-habilitation and rehabilitation in cancer

  • H.    Equity, diversity and inclusion in cancer care and research

  • I.      Health care provider wellness

  • J.      Implementation science, knowledge translation and synthesis

  • K.     Innovation in psychosocial oncology interventions

  • L.     Palliative and end-of-life care

  • M.   Pandemics and cancer care issues

  • N.    Patient oriented research approaches

  • O.    Primary, secondary and tertiary cancer prevention

  • P.     Sociodemographic, culture, and sex/gender issues in cancer

  • Q.    Survivorship

  • R.    Other Value-based and person-centered cancer care

Abstract Selection Process

Abstracts will be judged on the following criteria:

  • Significance and relevance
  • Innovation
  • Approach and findings
  • Implications
  • Rigor and clarity

The CAPO 2024 Scientific Committee will select abstract for oral, poster and symposium presentations by April 26, 2024. The submitting author will receive an email with the decision. If a primary author cannot attend the conference, that author should assign a replacement. The scientific committee reserves the right to reallocate abstracts as necessary. All presenting authors must register for the conference.

For abstract-related inquiries, please contact [email protected]